Vista Pharmaceuticals Ltd

Vista-Pharmaceuticals-Ltd09 Dec 2024

Pharmaceuticals

₹

+0.31 (+2.71%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd

Pharmaceuticals

Vista-Pharmaceuticals-Ltd09 Dec 2024

₹

+0.31 (+2.71%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
12-Jun-2015	S	Vista Pharmaceuticals Ltd has informed BSE about the outcome of Board Meeting held on June 11, 2015 The Board of Directors of Vista Pharmaceuticals Limited (The Company') at its meeting held on 09.10.2012 has approved the Scheme for Reduction of Share Capital. Accordingly number of shares shall be held by shareholders will be altered as under: A share holder who is holding 100 Equity Shares of Rs. 10/- each aggregating to Rs.1,000/- shall hold (after reduction) 166 shares of Rs. 11- each aggregating to Rs.332/-. Accordingly number of shares shall be held by shareholders will be altered as under: A share holder who is holding 100 Equity Shares of Rs. 10/- each aggregating to Rs.1,000/- shall hold (after reduction) 166 shares of Rs. 11- each aggregating to Rs.332/-. SUB. :- Reduction of Capital of Vista Pharmaceuticals Ltd. (Scrip Code: 524711) Trading members of the Exchange are hereby informed that, Vista Pharmaceuticals Ltd. has fixed the Record Date for the purpose of Reduction of Share Capital of the company pursuant to the order passed by the Hon'ble High Court of Andhra Pradesh and Telangana. COMPANY NAME & CODE Vista Pharmaceuticals Ltd. (524711) RECORD DATE 26/06/2015 PURPOSE Reduction of share capital : Pursuant to the scheme of reduction: the paid up share capital of Vista Pharmaceuticals Ltd. shall stand reduced from Rs. 15,00,00,000/- divided into 1,50,00,000 fully paid up equity shares of Rs.10/- each to Rs.5,00,00,000/- divided into 50,00,000 equity shares of Rs.10/- each, and, Thereafter, there shall be a split in the par value of the equity shares from Rs. 10/- each to Rs. 2/- per share. Illustration: A Shareholder of the company holding 100 equity shares of Rs. 10/- each , shall hold (after reduction) 166 equity shares of Rs.2/- each. NO DEALINGS FROM DATE & SETT. NO. 25/06/2015 DR-060/2015-2016 Trading Members are requested to take note of the above. (As Per BSE Notice Dated on 17.06.2015)	26-Jun-2015
07-Nov-2024	BC	VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve 1. Un Audited financial results for	13-Nov-2024
08-Sep-2024	BC	Notice is hereby given that the 33rd Annual General Meeting of members of M/s. Vista Pharmaceuticals Ltd will be held on Monday, the 30th day of September 2024 at 10.30 A.M. (IST) through Video Con	30-Sep-2024
19-Sep-2024	BC	Annual General Meeting	24-Sep-2024
03-Aug-2024	BC	VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. Un Audited financial results for	13-Aug-2024
13-Aug-2024	BC	Financial results fro the quarter ended 30.06.2024	13-Aug-2024

No Rights has been declared by Vista-Pharmaceuticals-Ltd

Book Closure

Record Date	Split Date	Purpose
13-Nov-2024	-	VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve 1. Un Audited financial results for
30-Sep-2024	-	Notice is hereby given that the 33rd Annual General Meeting of members of M/s. Vista Pharmaceuticals Ltd will be held on Monday, the 30th day of September 2024 at 10.30 A.M. (IST) through Video Con
24-Sep-2024	01 Jan'1900	Annual General Meeting
13-Aug-2024	-	VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. Un Audited financial results for
13-Aug-2024	-	Financial results fro the quarter ended 30.06.2024

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vista Pharmaceuticals Ltd ₹11.76(+0.31/2.71%)	11.76	+0.31	44.45	-34.38	0.00	1.02
Ambalal Sarabhai Enterprises Ltd ₹59.95(+1.58/2.71%)	59.95	+1.58	447.31	43.06	50.76	9.93
Astrazeneca Pharma India Ltd ₹6,660.00(+27.45/0.41%)	6,660.00	+27.45	16,581.38	37.91	128.81	24.41
Abbott India Ltd ₹29,090.15(+36.65/0.13%)	29,090.15	+36.65	61,738.69	25.91	48.06	17.53
Amrutanjan Health Care Ltd ₹734.00(+11.20/1.55%)	734.00	+11.20	2,089.66	21.23	43.97	7.02
Bliss GVS Pharma Ltd ₹155.95(-1.95/-1.23%)	155.95	-1.95	1,663.19	18.28	20.59	1.62

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	0.20	0.07	0.14	0.23	0.87
Net Cash from Operating Activities	-4.91	-1.71	-0.99	-6.75	0.80
Net Cash Used In Investing Activities	-0.79	-1.27	-0.01	-0.30	-1.73
Net Cash Used In Financing Activities	5.59	3.11	0.94	6.96	0.28
Net Inc./Dec In Cash And Cash Equivalents	-0.11	0.13	-0.07	-0.09	-0.64
Cash And Cash Equivalents At End Of The Year	0.09	0.20	0.07	0.14	0.23

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

21.19%

FII Shareholding

0.00%

DII Shareholding

0.02%

Public Shareholding

78.79%

**Promoter pledged shareholding 21.19%

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 44.45 crores. It has reported a sales of Rs. 2.49 crores and a net profit of Rs. -0.97 crores for the quarter ended December 2018. The company management includes Dhananjaya Alli, Dhananjaya Alli,G Narendra,M H Rao,Stanley Prabhakar Reddy,Umesh V Banakar,Chakravarthula Divya Bhavani,Umakanth Katta,Divakar Reddy Yerrabommanahalli,Murali Meraga,Pavan Sathvik Gilaka,Barkha Jain (Vista Pharmaceuticals Ltd) among others.

Chairman

Dhananjaya Alli

Registered office

Plot No 10to14 16to20 APIIC,Industrial Estate Chotyal,Nalgonda,Telangana,

FAX :91-08682-272551

Background

Incorporation Year1991

Face Value₹2

Market Lot1